SRNE — Sorrento Therapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro CapValue Trap

Annual balance sheet for Sorrento Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2018 December 31st	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	159	22.5	56.5	127	50
Net Total Accounts Receivable
Net Total Receivables	4.36	14.5	15.5	18.7	24.5
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	180	67.6	86.2	173	96.4
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	24.4	76.3	73.9	126	138
Net Goodwill
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	624	558	536	695	473
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	61.6	115	96.5	139	328
Long Term Debt
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Liabilities	415	479	371	616	491
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Other Equity
Total Equity	209	78.6	165	78.7	-18.6
Total Liabilities & Shareholders' Equity	624	558	536	695	473
Total Common Shares Outstanding